How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Liquid Calcium for Women Market
- By Product Form: Liquid Drops, Ready-to-Drink Bottles, Powdered Liquid Concentrate, Syrup
- By Calcium Source: Calcium Citrate, Calcium Carbonate, Calcium Lactate, Calcium Gluconate
- By Target Consumer Age Group: Adolescent Girls (12-18 years), Adult Women (19-50 years), Postmenopausal Women (50+ years)
- By Distribution Channel: Pharmacies and Drugstores, Online Retail, Health and Wellness Stores, Supermarkets and Hypermarkets
- By Packaging Type: Single-Dose Vials, Multi-Dose Bottles, Sachets
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Liquid Drops leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Liquid Calcium for Women Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Form 4
Calcium Source 4
Target Consumer Age Group 3
Distribution Channel 4
Packaging Type 3
Companies profiled
Pfizer Inc.
Bayer AG
Amway Corporation
Nature's Bounty Co.
GNC Holdings Inc.
Church & Dwight Co. Inc.
NOW Foods
Solgar Inc.
Herbalife Nutrition Ltd.
Blackmores Limited
Swisse Wellness Pty Ltd
Jamieson Wellness Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Pfizer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bayer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Amway Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nature's Bounty Co.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →GNC Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Church & Dwight Co. Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →NOW Foods
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Solgar Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Herbalife Nutrition Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Blackmores Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Swisse Wellness Pty Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Jamieson Wellness Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →New Chapter Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Garden of Life
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Caltrate (a brand by Pfizer)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,712M by 2033 · 3.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Liquid Drops55.8
- Ready-to-Drink Bottles14.9
- Powdered Liquid Concentrate16.9
- Syrup12.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,142M → $1,565M · 4.0%
Europe$795.9M → $1,045M · 3.5%
Asia Pacific$726.7M → $920.7M · 3.0%
Latin America$449.9M → $595.4M · 3.6%
Middle East and Africa$346.1M → $475.1M · 4.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.892026
3.902027
3.902028
3.922029
3.942030
3.942031
3.962032
3.972033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Pfizer Inc.11.7
- Bayer AG11.3
- Amway Corporation8.9
- Nature's Bounty Co.14.7
- GNC Holdings Inc.12.7
- Church & Dwight Co. Inc.12.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form21.2%
Calcium Source17.8%
Target Consumer Age Group25.2%
Distribution Channel10.4%
Packaging Type25.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.0
- Europe22.7
- Asia Pacific20.0
- Latin America12.9
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 81 | 83 | 90 | 80 | 74 | 77 | 81 |
| Bayer AG | 80 | 86 | 85 | 69 | 81 | 93 | 82 |
| Amway Corporation | 75 | 84 | 87 | 70 | 69 | 84 | 78 |
| Nature's Bounty Co. | 57 | 65 | 81 | 65 | 69 | 57 | 66 |
| GNC Holdings Inc. | 63 | 59 | 69 | 75 | 58 | 71 | 66 |
| Church & Dwight Co. Inc. | 63 | 65 | 57 | 70 | 49 | 51 | 59 |
| NOW Foods | 42 | 51 | 53 | 56 | 60 | 49 | 52 |
| Solgar Inc. | 38 | 50 | 52 | 45 | 59 | 44 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Pfizer Inc.
- Bayer AG
- Amway Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Pfizer Inc. | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Bayer AG | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Amway Corporation | ◐ | ✓ | ✓ | ✓ | − | ✓ |
| Nature's Bounty Co. | − | − | ◐ | ◐ | ◐ | ◐ |
| GNC Holdings Inc. | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Church & Dwight Co. Inc. | ◐ | − | − | − | − | ◐ |
| NOW Foods | − | ◐ | − | − | ◐ | ◐ |
| Solgar Inc. | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bayer AG82
2Pfizer Inc.81
3Amway Corporation78
4Nature's Bounty Co.66
5GNC Holdings Inc.66
6Church & Dwight Co. Inc.59
7NOW Foods52
8Solgar Inc.48
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Pfizer Inc.Bayer AGAmway Corporation
Contender3
Focused players with pockets of strength.
Nature's Bounty Co.GNC Holdings Inc.Church & Dwight Co. Inc.
Niche2
Specialists in a single segment or region.
NOW FoodsSolgar Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across Liquid Calcium for Women Market — a $247M beachhead inside a $4.45B market.
Beachhead (SOM)$247Mobtainable near-term
Serviceable (SAM)$1.57Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Liquid Drops
Best fit — highest urgency & budget in Product Form.
Economic buyer81 fit
Ready-to-Drink Bottles
Strong fit — clear ROI and a fast path to value.
End user69 fit
Powdered Liquid Concentrate
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Calcium Source & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Consumer Age Group
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel28%
Digital / self-serve21%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Liquid Calcium for Women Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified22%
Evaluation14%
Closed-won5%
$9.7KCAC
$41KLTV
4.2:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Liquid Calcium for Women Market is a durable-growth opportunity — $10.7B by 2033, compounding at 9.8%.
TAM · 2025$5.04Btoday
TAM · 2033$10.7Bforecast
CAGR9.8%2027–2033
Cumulative$67.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.7BTotal addressable market
SAM$4.10BServiceable available market
SOM$753MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.8% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.7BLarge & growingTAM by 2033 at 9.8% CAGR
$4.10BServiceable nowreachable with today’s model
$753MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.32BBear6.4% CAGR
$10.7BBase9.8% CAGR
$13.7BBull13.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Calcium Source optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Liquid Calcium for Women Market — a $2.65B market by 2033. Plan: grow share from 9.5% to 17.8%.
Market size · 2033$2.65Btotal addressable
Market CAGR9.4%2027–2033
Target share17.8%from 9.5% today
Revenue ambition$472Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.5% | 17.8% | On track |
| Revenue | $272M | $472M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 37.4% | 41.7% | On track |
| Customer retention | 86.9% | 92.4% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Calcium Source capability
A defensible second engine — invest in Calcium Source to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Calcium Source
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $47M capacity & capability investment
- Greenlight bolt-on M&A in Calcium Source
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Liquid Calcium for Women Market conversation — a $3.45B market you can size, segment and defend in minutes.
Market size · 2033$3.45Btotal opportunity
Growth5.9%CAGR to 2033
Addressable buyers1,401+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 4 mopayback period
$70K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Pfizer Inc.Bayer AGAmway CorporationNature's Bounty Co.GNC Holdings Inc.Church & Dwight Co. Inc.NOW FoodsSolgar Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Liquid Calcium for Women Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Liquid Calcium for Women Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Liquid-borne Particle Counters for Pharmaceutical Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportLiquid Biopsy Tube Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportLiquid Biopsy Technology Market
Liquid Biopsy Technology Market is valued at USD 8.36 Billion in 2025 and is expected to reach …
$8.4B market · 2025 base year
View reportLiquid Biopsy Services Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportLiquid Biopsy IVD Market
Market size, share, segmentation and regional forecast.
$588M market · 2025 base year
View reportLiquid Biopsy Diagnostic Tool Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportLiquid Biochip Analyzer Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportLiquid Bath Calibrator Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportLiquid-Based Tlc Cell Film Maker Market
Market size, share, segmentation and regional forecast.
$822M market · 2025 base year
View reportLiquid-based Thin Layer Cell Processor Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportLiquid-Based Cytology (LBC) Slide Processor and Staining System Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportLiquid-Based Cell Preservation Solution Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.